Ipilimumab/nivolumab/pembrolizumabVarious toxicities: 6 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1924卷 / 1期

关键词：

D O I：

10.1007/s40278-022-23615-0

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：262 / 262

相关论文

共 50 条

[21] Ipilimumab/nivolumab/pembrolizumabVarious toxicities: 14 case reports
Reactions Weekly, 2021, 1882 (1) : 257 - 257
[22] Ipilimumab/nivolumab/pembrolizumabVarious toxicities: 9 case reports
Reactions Weekly, 2018, 1704 (1) : 209 - 210
[23] Ipilimumab/nivolumab/pembrolizumabVarious toxicities: 13 case reports
Reactions Weekly, 2017, 1648 (1) : 170 - 170
[24] Ipilimumab/nivolumab/pembrolizumabVarious toxicities: 3 case reports
Reactions Weekly, 2021, 1886 (1) : 240 - 240
[25] Ipilimumab/nivolumab/pembrolizumabVarious toxicities: 2 case reports
Reactions Weekly, 2019, 1780 (1) : 200 - 200
[26] Ipilimumab/nivolumab/pembrolizumabVarious toxicities: 5 case reports
Reactions Weekly, 2020, 1800 (1) : 180 - 180
[27] Ipilimumab/nivolumab/pembrolizumabVarious toxicities: 8 case reports
Reactions Weekly, 2020, 1795 (1) : 165 - 165
[28] Ipilimumab/nivolumab/pembrolizumabVarious toxicities: 4 case reports
Reactions Weekly, 2021, 1857 (1) : 183 - 183
[29] Ipilimumab/nivolumab/pembrolizumabVarious toxicities: 13 case reports
Reactions Weekly, 2020, 1801 (1) : 154 - 154
[30] Ipilimumab/nivolumab/pembrolizumabVarious toxicities: 21 case reports
Reactions Weekly, 2020, 1805 (1) : 175 - 175

← 1 2 3 4 5 →